Blood test could personalize chemo breaks for advanced colon cancer
NCT ID NCT06446557
First seen Feb 21, 2026 · Last updated May 21, 2026 · Updated 16 times
Summary
This study tests whether a simple blood test (ctDNA) can help doctors decide when to reduce or change chemotherapy for people with advanced colorectal cancer that has spread. About 408 participants will be randomly assigned to either standard care or a strategy where the blood test guides treatment decisions. The goal is to see if this personalized approach improves survival while maintaining quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLON CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.